New stock news | Pujia Pharmaceutical Hong Kong stock IPO prospectus is invalid

According to the Securities Times app, the Hong Kong stock prospectus submitted by Beijing Puki Medicine Technology Co., Ltd. (referred to as Puki Medicine) on January 21, 2026 expired after 6 months on July 21, 2026. CITIC Securities and Minsheng Capital served as joint sponsors.